Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.37 USD 3.27% Market Closed
Market Cap: 107.4m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Intrinsic Value

DERM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one DERM stock under the Base Case scenario is 3.75 USD. Compared to the current market price of 5.37 USD, Journey Medical Corp is Overvalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DERM Intrinsic Value
3.75 USD
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Journey Medical Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DERM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DERM?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Journey Medical Corp

Provide an overview of the primary business activities
of Journey Medical Corp.

What unique competitive advantages
does Journey Medical Corp hold over its rivals?

What risks and challenges
does Journey Medical Corp face in the near future?

Has there been any significant insider trading activity
in Journey Medical Corp recently?

Summarize the latest earnings call
of Journey Medical Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Journey Medical Corp.

Provide P/S
for Journey Medical Corp.

Provide P/E
for Journey Medical Corp.

Provide P/OCF
for Journey Medical Corp.

Provide P/FCFE
for Journey Medical Corp.

Provide P/B
for Journey Medical Corp.

Provide EV/S
for Journey Medical Corp.

Provide EV/GP
for Journey Medical Corp.

Provide EV/EBITDA
for Journey Medical Corp.

Provide EV/EBIT
for Journey Medical Corp.

Provide EV/OCF
for Journey Medical Corp.

Provide EV/FCFF
for Journey Medical Corp.

Provide EV/IC
for Journey Medical Corp.

Show me price targets
for Journey Medical Corp made by professional analysts.

What are the Revenue projections
for Journey Medical Corp?

How accurate were the past Revenue estimates
for Journey Medical Corp?

What are the Net Income projections
for Journey Medical Corp?

How accurate were the past Net Income estimates
for Journey Medical Corp?

What are the EPS projections
for Journey Medical Corp?

How accurate were the past EPS estimates
for Journey Medical Corp?

What are the EBIT projections
for Journey Medical Corp?

How accurate were the past EBIT estimates
for Journey Medical Corp?

Compare the revenue forecasts
for Journey Medical Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Journey Medical Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Journey Medical Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Journey Medical Corp compared to its peers.

Compare the P/E ratios
of Journey Medical Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Journey Medical Corp with its peers.

Analyze the financial leverage
of Journey Medical Corp compared to its main competitors.

Show all profitability ratios
for Journey Medical Corp.

Provide ROE
for Journey Medical Corp.

Provide ROA
for Journey Medical Corp.

Provide ROIC
for Journey Medical Corp.

Provide ROCE
for Journey Medical Corp.

Provide Gross Margin
for Journey Medical Corp.

Provide Operating Margin
for Journey Medical Corp.

Provide Net Margin
for Journey Medical Corp.

Provide FCF Margin
for Journey Medical Corp.

Show all solvency ratios
for Journey Medical Corp.

Provide D/E Ratio
for Journey Medical Corp.

Provide D/A Ratio
for Journey Medical Corp.

Provide Interest Coverage Ratio
for Journey Medical Corp.

Provide Altman Z-Score Ratio
for Journey Medical Corp.

Provide Quick Ratio
for Journey Medical Corp.

Provide Current Ratio
for Journey Medical Corp.

Provide Cash Ratio
for Journey Medical Corp.

What is the historical Revenue growth
over the last 5 years for Journey Medical Corp?

What is the historical Net Income growth
over the last 5 years for Journey Medical Corp?

What is the current Free Cash Flow
of Journey Medical Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Journey Medical Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Journey Medical Corp

Current Assets 46.5m
Cash & Short-Term Investments 23.9m
Receivables 10.5m
Other Current Assets 12.1m
Non-Current Assets 18.7m
PP&E 55k
Intangibles 18.7m
Other Non-Current Assets 6k
Current Liabilities 34.1m
Accounts Payable 14.9m
Accrued Liabilities 16.3m
Other Current Liabilities 3m
Non-Current Liabilities 19.7m
Long-Term Debt 19.7m
Efficiency

Earnings Waterfall
Journey Medical Corp

Revenue
77.7m USD
Cost of Revenue
-25.8m USD
Gross Profit
51.9m USD
Operating Expenses
-49.8m USD
Operating Income
2.1m USD
Other Expenses
-1.3m USD
Net Income
844k USD

Free Cash Flow Analysis
Journey Medical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Journey Medical's Q2 2024 net product revenue was $14.9 million, keeping them on track for annual guidance of $55-60 million. Key products, QBREXZA and Accutane, showed prescription growth. Gross profit margins improved due to product mix and reduced royalties. The company achieved its fourth consecutive quarter of positive non-GAAP adjusted EBITDA, with $300,000 in Q2, while reducing SG&A expenses by 15%. Journey Medical focuses on securing FDA approval for DFD-29, targeting a launch in late Q1 2025. They plan to leverage market exclusivity until 2039, eyeing significant growth in the $1.2 billion rosacea treatment market.

What is Earnings Call?
Fundamental Scores

DERM Profitability Score
Profitability Due Diligence

Journey Medical Corp's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive Revenue Growth Forecast
Positive ROE
29/100
Profitability
Score

Journey Medical Corp's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

DERM Solvency Score
Solvency Due Diligence

Journey Medical Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
Average D/E
33/100
Solvency
Score

Journey Medical Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DERM Price Targets Summary
Journey Medical Corp

Wall Street analysts forecast DERM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DERM is 10.2 USD with a low forecast of 9.09 USD and a high forecast of 11.55 USD.

Lowest
Price Target
9.09 USD
69% Upside
Average
Price Target
10.2 USD
90% Upside
Highest
Price Target
11.55 USD
115% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DERM?

Click here to dive deeper.

Dividends

Journey Medical Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for DERM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DERM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Journey Medical Corp Logo
Journey Medical Corp

Country

United States of America

Industry

Pharmaceuticals

Market Cap

107.5m USD

Dividend Yield

0%

Description

Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. The company is headquartered in Scottsdale, Arizona and currently employs 90 full-time employees. The company went IPO on 2021-11-12. The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company provides nine products that help treat and heal common skin conditions, such as Qbrexza, Accutane, Targadox, Ximino, Exelderm Cream and Solution, Ceracade Skin Emulsion, Luxamend Wound Cream, AMZEEQ and ZILXI. Its product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne; Exelderm Cream and Solution is an antifungal intended for topical use; Ceracade Skin Emulsion is used to treat dry skin conditions; AMZEEQ is used for the treatment of acne and ZILXI, for the treatment of rosacea.

Contact

ARIZONA
Scottsdale
9237 E Via De Ventura Blvd., Suite 105, Suite 105
+14804346670.0
journeymedicalcorp.com

IPO

2021-11-12

Employees

90

Officers

Executive Chairman
Dr. Lindsay Allan Rosenwald
Founder, President, CEO & Director
Mr. Claude Maraoui
CFO & Corporate Controller
Mr. Joseph M. Benesch
Vice President of Operations
Mr. Andrew J. Zwible
General Counsel & Company Secretary
Mr. Ramsey Alloush
Chief Commercial Officer
Mr. Robert Nevin
Show More
Senior Director of Corporate Operations
Jaclyn Jaffe
Show Less

See Also

Discover More
What is the Intrinsic Value of one DERM stock?

The intrinsic value of one DERM stock under the Base Case scenario is 3.75 USD.

Is DERM stock undervalued or overvalued?

Compared to the current market price of 5.37 USD, Journey Medical Corp is Overvalued by 30%.

Back to Top